Literature DB >> 31621569

Osteoarthritis is as severe as rheumatoid arthritis: evidence over 40 years according to the same measure in each disease.

Theodore Pincus1, Isabelle Castrejon2, Yusuf Yazici3, Kathryn A Gibson4, Martin J Bergman5, Joel A Block2.   

Abstract

Osteoarthritis (OA) may be associated with substantial work disability, morbidity, costs, and increased mortality rates, often similar to rheumatoid arthritis (RA), documented in many published reports over the last 4 decades. However, OA generally has been viewed as less severe than RA. This discrepancy may be explained in part by:a) RA may have been considerably more severe in the past, prior to effective therapies.b) most older individuals have radiographic joint damage, which often is not associated with clinical symptoms.c) RA is associated with abnormal laboratory tests, which are regarded as conveying greater significance than symptoms of pain and disability according to a "biomedical model," the dominant paradigm of modern medicine.d) Most reports of OA and RA have emphasised differences between the 2 diseases even beyond laboratory abnormalities in pathogenesis, physical findings, and imaging.e) Even pain and functional disability seen in both diseases are assessed using different patient self-report questionnaires, a WOMAC (Western Ontario McMaster Universities osteoarthritis index) in OA, and HAQ (health assessment questionnaire) in RA.An identical measure is required for optimal direct comparisons, which has been used in 8 studies performed between 1979 and 2019 at 8 sites in North America, Europe, and Australia. These studies were primarily based on retrospective analyses at sites which collected a patient questionnaire in routine clinical care by all patients at all visits to inform clinical decisions. A pain visual analogue scale (VAS) was higher in OA compared to RA in 11/12 patient groups, while physical function on a HAQ (health assessment questionnaire) or derivative MDHAQ (multidimensional HAQ) and RAPID3 (routine assessment of patient index data) were slightly higher in RA before 2013 and higher in OA in later reports. Furthermore, a study of population-based data from the 1978 US Health Interview Survey indicated similar levels of disability and earnings losses according to surrogate variables for OA and RA. Therefore, at least over the last 40 years, pain and functional disability in OA have appeared to be severe and similar to RA. These observations also-illustrate the potential value of using an identical patient questionnaire in all patients at all visits in routine care settings, analogous to using the same laboratory tests such as erythrocyte sedimentation rate (ESR) or C-reactive protein (CRP) in all rheumatic diseases, and maintaining a database of the results for later analyses.

Entities:  

Mesh:

Year:  2019        PMID: 31621569

Source DB:  PubMed          Journal:  Clin Exp Rheumatol        ISSN: 0392-856X            Impact factor:   4.473


  7 in total

Review 1.  A Meta-Analysis of the Impact of Nutritional Supplementation on Osteoarthritis Symptoms.

Authors:  Sylvain Mathieu; Martin Soubrier; Cedric Peirs; Laurent-Emmanuel Monfoulet; Yves Boirie; Anne Tournadre
Journal:  Nutrients       Date:  2022-04-12       Impact factor: 6.706

2.  Effect of glucocorticoids combined with disease modifying anti-rheumatic drugs on the improvement of symptoms in patients with rheumatoid arthritis.

Authors:  Lulu Si; Yunyan Jin; Dongni Zhao; Lixia Yu; Huankun Cao
Journal:  Pak J Med Sci       Date:  2022 Mar-Apr       Impact factor: 2.340

3.  Analysis of the Associations between Arthritis and Fall Histories in Korean Adults.

Authors:  Jung Woo Lee; Seong Hun Kang; Hyo Geun Choi
Journal:  Int J Environ Res Public Health       Date:  2021-04-03       Impact factor: 3.390

Review 4.  New Trends in Pharmacological Treatments for Osteoarthritis.

Authors:  Xiaoyan Cai; Shiwen Yuan; Yanting Zeng; Cuicui Wang; Na Yu; Changhai Ding
Journal:  Front Pharmacol       Date:  2021-04-15       Impact factor: 5.810

5.  Burosumab treatment in adults with X-linked hypophosphataemia: 96-week patient-reported outcomes and ambulatory function from a randomised phase 3 trial and open-label extension.

Authors:  Karine Briot; Anthony A Portale; Maria Luisa Brandi; Thomas O Carpenter; Hae Ii Cheong; Martine Cohen-Solal; Rachel K Crowley; Richard Eastell; Yasuo Imanishi; Steven Ing; Karl Insogna; Nobuaki Ito; Suzanne Jan de Beur; Muhammad K Javaid; Peter Kamenicky; Richard Keen; Takuo Kubota; Robin H Lachmann; Farzana Perwad; Pisit Pitukcheewanont; Stuart H Ralston; Yasuhiro Takeuchi; Hiroyuki Tanaka; Thomas J Weber; Han-Wook Yoo; Annabel Nixon; Mark Nixon; Wei Sun; Angela Williams; Erik A Imel
Journal:  RMD Open       Date:  2021-09

6.  Transcription factor KLF4 regulated STAT1 to promote M1 polarization of macrophages in rheumatoid arthritis.

Authors:  Qiao Ye; Fang Luo; Tingting Yan
Journal:  Aging (Albany NY)       Date:  2022-06-24       Impact factor: 5.955

Review 7.  Emerging Technologies and Platforms for the Immunodetection of Multiple Biochemical Markers in Osteoarthritis Research and Therapy.

Authors:  Eiva Bernotiene; Edvardas Bagdonas; Gailute Kirdaite; Paulius Bernotas; Ursule Kalvaityte; Ilona Uzieliene; Christian S Thudium; Heidi Hannula; Gabriela S Lorite; Mona Dvir-Ginzberg; Ali Guermazi; Ali Mobasheri
Journal:  Front Med (Lausanne)       Date:  2020-10-21
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.